Emergent Biosolutions IncAdd to My Watchlist

EBS:USNew YorkIndustry: Medical-Biomedical/Gene
  • 25.89
    Last
  • 0.61  -2.30%
    Today's Change
  • 26.50
    Previous Close
  • Today
     
    13.88
    28.48
    52 Week Low - High
9:45 am ET 4/24/2014
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding37 million
Market Cap$966 million
Return on Equity ttm6.69%
Last DividendEBS:US does not pay a dividend
Earnings
EPS: Year Actual ttm0.898
EPS: Year Est. 12/14 ttm1.025
 
EPS: Quarterly Actual 12/13 0.41
EPS: Quarterly Est. 3/14 -0.34
 
Price/Earnings ttm28.82
Relative Price/Earnings1.680
Earnings Growth Rate32.31
Company Description
Emergent Biosolutions, Inc. develops and produces immunobiotics, pharmaceutical products that assist the body's immune system to prevent or treat disease. The Company produces a vaccine for anthrax.
Revenue$313 million
Net Income$31 million
Total Assets$627 million
Employees1,353
Web Sitewww.emergentbiosolutions.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!